Počet záznamů: 1  

Genetically modified cellular vaccines against human papillomavirus type 16 (HPV16)-associated tumors: adjuvant treatment of minimal residual disease after surgery/chemotherapy

  1. 1.
    SYSNO ASEP0346751
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevGenetically modified cellular vaccines against human papillomavirus type 16 (HPV16)-associated tumors: adjuvant treatment of minimal residual disease after surgery/chemotherapy
    Tvůrce(i) Bubeník, Jan (UMG-J)
    Šímová, Jana (UMG-J) RID
    Zdroj.dok.Journal of Balkan Union of Oncology - ISSN 1107-0625
    Roč. 14, č. 1 (2009), s. 169-173
    Poč.str.5 s.
    Jazyk dok.eng - angličtina
    Země vyd.GR - Řecko
    Klíč. slovaresidual tumour disease ; HPV16 ; cellular vaccines
    Vědní obor RIVEB - Genetika a molekulární biologie
    CEPGA301/06/0774 GA ČR - Grantová agentura ČR
    GA301/07/1410 GA ČR - Grantová agentura ČR
    CEZAV0Z50520514 - UMG-J (2005-2011)
    UT WOS000270421500021
    AnotaceLocal recurrences at the site of tumour resection or after chemotherapy, as well as distant micrometastases represent major problems in oncology. Genetically modified cellular vaccines were found to be efficient against cancer both in experimental models and in tumour-bearing patients. It was also shown in various systems that the efficacy of conventional therapeutic modalities can be supported by adjuvant administration of genetically modified vaccines, as well as by depletion of immunosuppressive immunocyte subsets. The purpose of this review is to summarize and evaluate the results obtained with administration of genetically modified cellular vaccines as well as with depletion of immunosuppressive immunocytes performed as treatment of the minimal residual tumour disease after surgery / chemotherapy in the experimental model of murine tumours mimicking human HPV 16-associated neoplasms. The prospects and limitations of these adjuvant immunotherapeutic modalities will be discussed.
    PracovištěÚstav molekulární genetiky
    KontaktNikol Škňouřilová, nikol.sknourilova@img.cas.cz, Tel.: 241 063 217
    Rok sběru2011
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.